Olivia Andersen

Olivia Andersen is a Research Assistant in the lab of Professor Sarah Rowland-Jones at the University of Oxford, where she is focused on investigating drug resistance mutations in adolescents living with HIV in Zambia and Zimbabwe as a part of the VITALITY trial. Her research centers on the characterization of these mutations in the current era of large-scale implementation of integrase inhibitor-based antiretroviral regimens in the region. She is particularly interested in understanding the mechanisms that drive the emergence of these mutations within individuals and populations, as well as the development of new antiretroviral therapies aimed at mitigating their impact. Before joining the University of Oxford, Olivia completed her MSc in Immunology at Imperial College London, where she completed her thesis under Professor David Thomas.